NLM Logo

nimotuzumab MeSH Supplementary Concept Data 2021


MeSH Supplementary
nimotuzumab
Unique ID
C501466
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C501466
Entry Term(s)
Theraloc
theracim-HR3
Pharm Action
Antineoplastic Agents, Immunological
Registry Number
6NS400BXKH
CAS Type 1 Name
Immunoglobulin G1, anti-(humanized mouse monoclonal hR3 beta1 chain anti-human epidermal growth factor receptor), disulfide with humanized mouse monoclonal hR3 kappa-chain, dimer
Previous Indexing
*ANTIBODIES, MONOCLONAL (2005-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
202
Note
a humanized monoclonal antibody that binds to the epidermal growth factor receptor
Source
Curr Opin Mol Ther 2005 Apr;7(2):182-91
Date of Entry
2005/06/23
Revision Date
2019/10/31
nimotuzumab Preferred
theracim-HR3 Narrower
Theraloc Narrower
page delivered in 0.008s